|
乳腺癌组织中paxillin和c erbB 2的表达及临床意义 |
| |
f fibronectin signaling[J]. Mol Cell Biol, 2002,22（3）: 901-915.
[9] Slamon DJ, Clark GM, Wong SG, et al .Human breast cancer: correlation of relapse and survival with amplication of the HER-2/neu oncogene[J]. Science,1987, 235（1）:177-182.
[10] Ferrero-Pous M, Hacene K, Bouchet C, et al. Relationship Between c-erbB-2 and other tumor characteristics in breast cancer prognosis[J]. Clin Cancer Res, 2000,6（12） :4745- 4754.
[11] Jukkola A, Bloigu R, Soini Y, et al. C-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease[J]. Eur J Cancer, 2001,37（3）:347-354.
[12] Boudreau NJ, Jones PL. Extracellular matrix and integrin signaling: the shape of things to come[J]. Bilchem J, 1999,33（pt3）:481-488.
上一页 [1] [2] [3] [4]
上一个医学论文： 探讨改良线栓对局灶脑缺血模型制备的影响
下一个医学论文： 肛门坠胀的病因剖析
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 儿科论文 >> 正文